Recent advances in biotin-based therapeutic agents for cancer therapy

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Dongming Xing

doi:10.1039/d4nr03729d

Recent advances in biotin-based therapeutic agents for cancer therapy

Dongming Xing · 2025-01-23

Biotin binds to drugs in two main modes: SMBCs and NBCs. Tumor cells have more biotin receptors than normal cells, allowing for greater biotin uptake, which can enhance drug delivery to tumors.

Recent advances in biotin-based therapeutic agents for cancer therapy

Links

Journal

Institutions

Authors

Funding